{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38626042", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": ["e0298201", "10.1371/journal.pone.0298201"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "16"}], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "19", "Issue": "4", "PubDate": {"Year": "2024"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease.", "Pagination": {"StartPage": "e0298201", "MedlinePgn": "e0298201"}, "Abstract": {"AbstractText": ["Covid-19 disease caused by the deadly SARS-CoV-2 virus is a serious and threatening global health issue declared by the WHO as an epidemic. Researchers are studying the design and discovery of drugs to inhibit the SARS-CoV-2 virus due to its high mortality rate. The main Covid-19 virus protease (Mpro) and human transmembrane protease, serine 2 (TMPRSS2) are attractive targets for the study of antiviral drugs against SARS-2 coronavirus. Increasing consumption of herbal medicines in the community and a serious approach to these drugs have increased the demand for effective herbal substances. Alkaloids are one of the most important active ingredients in medicinal plants that have wide applications in the pharmaceutical industry. In this study, seven alkaloid ligands with Quercetin nucleus for the inhibition of Mpro and TMPRSS2 were studied using computational drug design including molecular docking and molecular dynamics simulation (MD). Auto Dock software was used to evaluate molecular binding energy. Three ligands with the most negative docking score were selected to be entered into the MD simulation procedure. To evaluate the protein conformational changes induced by tested ligands and calculate the binding energy between the ligands and target proteins, GROMACS software based on AMBER03 force field was used. The MD results showed that Phyllospadine and Dracocephin-A form stable complexes with Mpro and TMPRSS2. Prolinalin-A indicated an acceptable inhibitory effect on Mpro, whereas it resulted in some structural instability of TMPRSS2. The total binding energies between three ligands, Prolinalin-A, Phyllospadine and Dracocephin-A and two proteins MPro and TMRPSS2 are (-111.235 \u00b1 15.877, - 75.422 \u00b1 11.140), (-107.033 \u00b1 9.072, -84.939 \u00b1 10.155) and (-102.941 \u00b1 9.477, - 92.451 \u00b1 10.539), respectively. Since the binding energies are at a minimum, this indicates confirmation of the proper binding of the ligands to the proteins. Regardless of some Prolinalin-A-induced TMPRSS2 conformational changes, it may properly bind to TMPRSS2 binding site due to its acceptable binding energy. Therefore, these three ligands can be promising candidates for the development of drugs to treat infections caused by the SARS-CoV-2 virus."], "CopyrightInformation": "Copyright: \u00a9 2024 Mohebbi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited."}, "AuthorList": [{"Identifier": ["0000-0002-2303-7231"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, Faculty of Engineering, Shahid Bahonar University of Kerman, Kerman, Iran."}], "LastName": "Mohebbi", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Committee of Faculty of Pharmacy, Lorestan University of Medical Science, Khorramabad, Iran."}], "LastName": "Eskandarzadeh", "ForeName": "Marzieh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, Faculty of Engineering, Shahid Bahonar University of Kerman, Kerman, Iran."}], "LastName": "Zangi", "ForeName": "Hanieh", "Initials": "H"}, {"Identifier": ["0000-0002-9687-2182"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, Faculty of Engineering, Shahid Bahonar University of Kerman, Kerman, Iran."}], "LastName": "Fatehi", "ForeName": "Marzie", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["chemistry"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antiviral Agents"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Fehr A.R. and Perlman S., Coronaviruses: An Overview of Their Replication and Pathogenesis (Book Chapter), Coronaviruses: Methods and Protocols, Springer Science+Business Media New York, 2015: p. 1\u201323.", "ArticleIdList": ["PMC4369385", "25720466"]}, {"Citation": "Odega K.; Iyamah E.; Ibadin E.; Idomeh F.; odega D. Safe laboratory practices in the light of Covid-19 pandemic: way forward in a resource limited setting. Preprints 2020, 2020040103. doi: 10.20944/preprints202004.0103.v1", "ArticleIdList": ["10.20944/preprints202004.0103.v1"]}, {"Citation": "Wu C., et al.., Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 2020. 10(5): p. 766\u2013788. doi: 10.1016/j.apsb.2020.02.008", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "Zarei A., et al.., In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds. Natural Product Research, 2022. 36(16): p. 4254\u20134260.", "ArticleIdList": ["34498974"]}, {"Citation": "Sajed A.N. and Amgain K., Corona virus disease (COVID-19) outbreak and the strategy for prevention. Europasian Journal of Medical Sciences, 2020. 2(1): p. 1\u20133."}, {"Citation": "Hussain M., et al.., Structural basis of SARS-CoV-2 spike protein priming by TMPRSS2. BioRxiv, 2020: p. 2020.04. 21.052639."}, {"Citation": "Yamamoto V., et al.., COVID-19: Review of a 21st century pandemic from etiology to neuro-psychiatric implications. Journal of Alzheimer\u2019s Disease, 2020. 77(2): p. 459\u2013504. doi: 10.3233/JAD-200831", "ArticleIdList": ["10.3233/JAD-200831", "PMC7592693", "32925078"]}, {"Citation": "Yadav R., et al.., Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells, 2021. 10(4): p. 821. doi: 10.3390/cells10040821", "ArticleIdList": ["10.3390/cells10040821", "PMC8067447", "33917481"]}, {"Citation": "Huang J., et al.., Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19. Journal of Clinical Medicine, 2020. 9(4): p. 1131. doi: 10.3390/jcm9041131", "ArticleIdList": ["10.3390/jcm9041131", "PMC7231166", "32326602"]}, {"Citation": "Zhang Q., et al.., Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduction and Targeted Therapy, 2021. 6(1): p. 233. doi: 10.1038/s41392-021-00653-w", "ArticleIdList": ["10.1038/s41392-021-00653-w", "PMC8193598", "34117216"]}, {"Citation": "Zhang X., Li S., and Niu S., ACE2 and COVID-19 and the resulting ARDS. Postgraduate Medical Journal, 2020. 96(1137): p. 403\u2013407. doi: 10.1136/postgradmedj-2020-137935", "ArticleIdList": ["10.1136/postgradmedj-2020-137935", "PMC10016912", "32522846"]}, {"Citation": "Senger M.R., et al.., COVID-19: molecular targets, drug repurposing and new avenues for drug discovery. Mem\u00f3rias do Instituto Oswaldo Cruz, 2020. 115. doi: 10.1590/0074-02760200254", "ArticleIdList": ["10.1590/0074-02760200254", "PMC7534958", "33027420"]}, {"Citation": "Mantzourani C., et al.., The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. Expert Opinion on Drug Discovery, 2022. 17(3): p. 231\u2013246. doi: 10.1080/17460441.2022.2029843", "ArticleIdList": ["10.1080/17460441.2022.2029843", "PMC8862169", "35072549"]}, {"Citation": "Hoffmann M., et al.., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cells, 2020. 181(2): p. 271\u2013280. e8. doi: 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Vincent M.J., et al.., Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, 2005. 2(1): p. 1\u201310. doi: 10.1186/1743-422X-2-69", "ArticleIdList": ["10.1186/1743-422X-2-69", "PMC1232869", "16115318"]}, {"Citation": "Nguyen T.T.H, et al.., Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett, 2012, 34, p. 831\u2013838. doi: 10.1007/s10529-011-0845-8", "ArticleIdList": ["10.1007/s10529-011-0845-8", "PMC7087583", "22350287"]}, {"Citation": "Singh H., et al.., ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microbial Pathogenesis, 2021. 150: p. 104621. doi: 10.1016/j.micpath.2020.104621", "ArticleIdList": ["10.1016/j.micpath.2020.104621", "PMC7709597", "33278516"]}, {"Citation": "Esam Z., et al.., In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19. Chemical Papers, 2023. 77(2): p. 1129\u20131148.", "ArticleIdList": ["PMC9589802", "36312321"]}, {"Citation": "Byl\u00e9hn F., et al.., Modeling the binding mechanism of remdesivir, favilavir, and ribavirin to SARS-CoV-2 RNA-dependent RNA polymerase. ACS Central Science, 2021. 7(1): p. 164\u2013174. doi: 10.1021/acscentsci.0c01242", "ArticleIdList": ["10.1021/acscentsci.0c01242", "PMC7805600", "33527086"]}, {"Citation": "Wang F., et al.., Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 2016. 6(1): p. 22677. doi: 10.1038/srep22677", "ArticleIdList": ["10.1038/srep22677", "PMC4780191", "26948040"]}, {"Citation": "Liang P.-H., Characterization and inhibition of SARS-coronavirus main protease. Current Topics in Medicinal Chemistry, 2006. 6(4): p. 361\u2013376. doi: 10.2174/156802606776287090", "ArticleIdList": ["10.2174/156802606776287090", "16611148"]}, {"Citation": "Jin Z., et al.., Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 2020. 582(7811): p. 289\u2013293. doi: 10.1038/s41586-020-2223-y", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Lee J., et al.., Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site. Nature Communications, 2020. 11(1): p. 5877. doi: 10.1038/s41467-020-19662-4", "ArticleIdList": ["10.1038/s41467-020-19662-4", "PMC7674412", "33208735"]}, {"Citation": "Zhao Y., et al.., Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332. Protein & Cell, 2022. 13(9): p. 689\u2013693. doi: 10.1007/s13238-021-00883-2", "ArticleIdList": ["10.1007/s13238-021-00883-2", "PMC8533666", "34687004"]}, {"Citation": "Kneller D.W., et al.., Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nature Communications, 2020. 11(1): p. 3202. doi: 10.1038/s41467-020-16954-7", "ArticleIdList": ["10.1038/s41467-020-16954-7", "PMC7314768", "32581217"]}, {"Citation": "Woo P.C., et al.., Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. Journal of Virology, 2012. 86(7): p. 3995\u20134008. doi: 10.1128/JVI.06540-11", "ArticleIdList": ["10.1128/JVI.06540-11", "PMC3302495", "22278237"]}, {"Citation": "Xia B. and Kang X., Activation and maturation of SARS-CoV main protease. Protein & Cell, 2011. 2(4): p. 282\u2013290. doi: 10.1007/s13238-011-1034-1", "ArticleIdList": ["10.1007/s13238-011-1034-1", "PMC4875205", "21533772"]}, {"Citation": "Majumder R. and Mandal M., Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach. Journal of Biomolecular Structure and Dynamics, 2022. 40(2): p. 696\u2013711.", "ArticleIdList": ["PMC7544942", "32897138"]}, {"Citation": "Wink M., Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19. Diversity, 2020. 12(5): p. 175."}, {"Citation": "Gonzalez B.L., et al.., The naturally\u2010derived alkaloids as a potential treatment for COVID\u201019: A scoping review. Phytotherapy Research, 2022. 36(7): p. 2686\u20132709. doi: 10.1002/ptr.7442", "ArticleIdList": ["10.1002/ptr.7442", "PMC9111026", "35355337"]}, {"Citation": "Majnooni M.B., et al.., Alkaloids as potential phytochemicals against SARS-CoV-2: approaches to the associated pivotal mechanisms. Evidence-based Complementary and Alternative Medicine, 2021. 2021.", "ArticleIdList": ["PMC8159655", "34104202"]}, {"Citation": "Bhambhani S., Kondhare K.R., and Giri A.P., Diversity in chemical structures and biological properties of plant alkaloids. Molecules, 2021. 26(11): p. 3374. doi: 10.3390/molecules26113374", "ArticleIdList": ["10.3390/molecules26113374", "PMC8199754", "34204857"]}, {"Citation": "Thawabteh A., et al.., The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens. Toxins, 2019. 11(11): p. 656. doi: 10.3390/toxins11110656", "ArticleIdList": ["10.3390/toxins11110656", "PMC6891610", "31717922"]}, {"Citation": "Pov\u0161nar M., et al.., Rare tradition of the folk medicinal use of Aconitum spp. is kept alive in Sol\u010davsko, Slovenia. Journal of Ethnobiology and Ethnomedicine, 2017. 13: p. 1\u201314.", "ArticleIdList": ["PMC5549329", "28789666"]}, {"Citation": "Friedman M., Potato glycoalkaloids and metabolites: roles in the plant and in the diet. Journal of Agricultural and Food Chemistry, 2006. 54(23): p. 8655\u20138681. doi: 10.1021/jf061471t", "ArticleIdList": ["10.1021/jf061471t", "17090106"]}, {"Citation": "Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al., The Protein Data Bank (2000) Nucleic Acids Research 28: 235\u2013242 doi: 10.1093/nar/28.1.235", "ArticleIdList": ["10.1093/nar/28.1.235", "PMC102472", "10592235"]}, {"Citation": "Hanwell M.D., et al.., Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 2012. 4(1): p. 1\u201317.", "ArticleIdList": ["PMC3542060", "22889332"]}, {"Citation": "Forli S., et al.., Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 2016. 11(5): p. 905\u2013919. doi: 10.1038/nprot.2016.051", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Lindahl A., Hess, & van der Spoel, GROMACS 2019.1 Manual (2019.1). Zenodo, 2019."}, {"Citation": "Fatehi M., Mohebbi A., and Moradi A.,Molecular dynamics insight into the behaviour of 5-nonylsalicylaldoxime and its complex with Cu (II) in different diluent/water systems. Journal of Molecular Liquids, 2019. 291: p.111350."}, {"Citation": "Kermani M.M. and Mohebbi A., Optimal loading of omecamtiv mecarbil by chitosan: A comprehensive and comparative molecular dynamics study. Journal of Molecular Liquids, 2021. 322: p.114908."}, {"Citation": "Bushehri M.K., Mohebbi A., and H Rafsanjani H., Prediction of thermal conductivity and viscosity of nanofluids by molecular dynamics simulation. Journal of Engineering Thermophysics, 2016. 25: pp.389\u2013400."}, {"Citation": "Gharaghani S., Khayamian T., and Ebrahimi M., Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. SAR and QSAR in Environmental Research, 2013. 24(9): p. 773\u2013794. doi: 10.1080/1062936X.2013.792877", "ArticleIdList": ["10.1080/1062936X.2013.792877", "23863115"]}, {"Citation": "Eskandarzadeh M., et al.., Inhibition of GSK_3\u03b2 by Iridoid Glycosides of Snowberry (Symphoricarpos albus) Effective in the Treatment of Alzheimer\u2019s Disease Using Computational Drug Design Methods. Frontiers in Chemistry, 2021. 9: p. 709932.", "ArticleIdList": ["PMC8529253", "34692636"]}, {"Citation": "Padhi A.K., et al.., Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations. European Journal of Pharmacology, 2021. 894: p. 173836. doi: 10.1016/j.ejphar.2020.173836", "ArticleIdList": ["10.1016/j.ejphar.2020.173836", "PMC7773528", "33387467"]}, {"Citation": "Saakre M., Mathew D., and Ravisankar V., Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2. Beni-Suef University Journal of Basic and Applied Sciences, 2021. 10(1): p. 1\u201313. doi: 10.1186/s43088-021-00107-w", "ArticleIdList": ["10.1186/s43088-021-00107-w", "PMC7989718", "33782651"]}, {"Citation": "Firouzi R., Ashouri M., and Karimi\u2010Jafari M.H., Structural insights into the substrate\u2010binding site of main protease for the structure\u2010based COVID\u201019 drug discovery. Proteins: Structure, Function, and Bioinformatics, 2022. 90(5): p. 1090\u20131101. doi: 10.1002/prot.26318", "ArticleIdList": ["10.1002/prot.26318", "35119780"]}, {"Citation": "Raschka S., et al.., Protein\u2013ligand interfaces are polarized: discovery of a strong trend for intermolecular hydrogen bonds to favor donors on the protein side with implications for predicting and designing ligand complexes. Journal of Computer-Aided Molecular Design, 2018. 32: p. 511\u2013528. doi: 10.1007/s10822-018-0105-2", "ArticleIdList": ["10.1007/s10822-018-0105-2", "29435780"]}, {"Citation": "Fraser B.J., et al.., Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation. BioRxiv, 2021: p. 2021.06. 23.449282.", "ArticleIdList": ["35676539"]}, {"Citation": "Idris M.O., et al.., Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics, 2021. 39(15): p. 5638\u20135656. doi: 10.1080/07391102.2020.1792346", "ArticleIdList": ["10.1080/07391102.2020.1792346", "PMC7441808", "32672528"]}, {"Citation": "Alzain A.A. and Elbadwi F.A., Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies. Informatics in Medicine Unlocked, 2021. 26: p. 100758. doi: 10.1016/j.imu.2021.100758", "ArticleIdList": ["10.1016/j.imu.2021.100758", "PMC8516157", "34667827"]}, {"Citation": "Gyebi G.A., et al.., Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2. J Biomol Struct Dyn, 2022. 40(5): p. 2121\u20132145.", "ArticleIdList": ["PMC7594191", "33089728"]}, {"Citation": "Kianipour S., et al.., A molecular dynamics study on using of naturally occurring polymers for structural stabilization of erythropoietin at high temperature. Journal of Biomolecular Structure and Dynamics, 2021: p. 1\u201311.", "ArticleIdList": ["33998953"]}, {"Citation": "Pourmand S., et al.., Inhibition of SARS-CoV-2 pathogenesis by potent peptides designed by the mutation of ACE2 binding region. Computers in Biology and Medicine, 2022: p. 105625. doi: 10.1016/j.compbiomed.2022.105625", "ArticleIdList": ["10.1016/j.compbiomed.2022.105625", "PMC9110306", "35688710"]}, {"Citation": "Shukla R., Munjal N.S., and Singh T.R., Identification of novel small molecules against GSK3\u03b2 for Alzheimer\u2019s disease using chemoinformatics approach. Journal of Molecular Graphics and Modelling, 2019. 91: p. 91\u2013104.", "ArticleIdList": ["31202091"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "26"}, {"Year": "2024", "Month": "1", "Day": "21"}, {"Year": "2024", "Month": "4", "Day": "18", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "4", "Day": "16", "Hour": "18", "Minute": "42"}, {"Year": "2024", "Month": "4", "Day": "16", "Hour": "14", "Minute": "4"}, {"Year": "2024", "Month": "4", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["38626042", "PMC11020608", "10.1371/journal.pone.0298201", "PONE-D-23-31183"]}}]}